Dimitrios C.
- Country
- Greece
- Department
- Department of Gastroenterology
Research Overview
- Metronidazole‑based drug combination versus standard therapy for Helicobacter pylori infection in adults
- Efficacy and Safety of Risankizumab in Maintenance and Long-term Extension for Moderately to Severely Active Crohn's Disease: A Randomized, Double-Blind, Placebo-Controlled Study
- Phase 2 Adaptive Dose-Ranging Study of Eltrekibart and Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis
Data & Insights
Has run more than one trial at 75 of 236 partner sites.
Specializations
Gastroenterology and Inflammatory Bowel Disease
Clinical research activity includes Crohn’s disease and ulcerative colitis, with interest in therapies targeting intestinal inflammation and long-term disease control.
- Crohn’s disease
- Ulcerative colitis
- Immune-mediated gastrointestinal disease
Work in this area aligns with biologic and advanced immunomodulatory approaches for chronic inflammatory bowel disease.
Respiratory Medicine and Pulmonary Fibrosis
The investigator is involved in studies on asthma, chronic obstructive pulmonary disease, bronchiectasis, and idiopathic pulmonary fibrosis, reflecting a broad focus on chronic airway and interstitial lung disorders.
- Asthma
- Chronic obstructive pulmonary disease
- Idiopathic pulmonary fibrosis
- Bronchiectasis
Therapeutic interest extends to exacerbation prevention, lung function preservation, and treatment of progressive fibrosing lung disease.
Cardiovascular and Metabolic Risk
Research involvement covers atherosclerotic cardiovascular disease, myocardial infarction, stroke prevention, heart failure, hypertension, dyslipidaemia, obesity, and type 2 diabetes.
- Atherosclerotic cardiovascular disease
- Acute myocardial infarction
- Stroke prevention
- Heart failure
- Hypertension
This domain includes therapies aimed at reducing vascular events, improving cardiometabolic control, and addressing residual inflammatory risk.
Nephrology and Renal Immunology
Clinical trial activity includes chronic kidney disease, IgA nephropathy, proteinuria, and other immune-mediated renal disorders, with attention to kidney preservation and inflammatory renal injury.
- Chronic kidney disease
- IgA nephropathy
- Proteinuria
- Idiopathic immune complex mediated membranoproliferative glomerulonephritis
Interest also extends to renal complications linked to systemic disease and progressive kidney dysfunction.
Hematology, Oncology, and Immune Disorders
The investigator is active in studies of multiple myeloma, lymphoma, myelofibrosis, acute myeloid leukemia, chronic myeloid leukemia, thalassemia, and autoimmune disease, including idiopathic inflammatory myopathy and multiple sclerosis.
- Multiple myeloma
- Lymphoma
- Myelofibrosis
- Thalassemia
- Autoimmune and inflammatory disorders
Research in this area includes targeted treatment strategies for malignant, hematologic, and immune-mediated conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.